 patholog chang androgen depriv therapi prostat cancer prostat gland depriv leuprolid flutamid patholog chang pretreat posttreat tissu visual discrimin light microscop studi treatment-rel alter size distribut neoplast gland case quantit measur glandular chang percentag case distinct histolog pattern specif leuprolide/flutamid absenc appreci degener necrosi tumor cell type androgen depriv suppress ablat prostat cancer relationship treatment-rel histolog effect initi tumor grade clinic stage express prostate-specif antigen accur histolog assess leuprolide/flutamide-tr prostat gland problem specimen drug-rel variat tumor morpholog featur